A fragment of the HMGN2 protein homes to the nuclei of tumor cells and tumor endothelial cells in vivo - Wikidata - awgldk - TriplyDB

A fragment of the HMGN2 protein homes to the nuclei of tumor cells and tumor endothelial cells in vivo

A fragment of the HMGN2 protein homes to the nuclei of tumor cells and tumor endothelial cells in vivo

http://www.wikidata.org/entity/Q24530544

about

Nanocrystal targeting in vivo.Peptides as targeting probes against tumor vasculature for diagnosis and drug delivery Peptide-conjugated antisense oligonucleotides for targeted inhibition of a transcriptional regulator in vivo HMGN2: a novel antimicrobial effector molecule of human mononuclear leukocytes?Polymer-Protein Hydrogel Nanomatrix for Stabilization of Indocyanine Green towards Targeted Fluorescence and Photoacoustic Bio-imaging.FUNCTIONAL NANOPARTICLES FOR MOLECULAR IMAGING GUIDED GENE DELIVERY Enhanced baculovirus-mediated transduction of human cancer cells by tumor-homing peptides Radiation-guided gene therapy of cancer.Molecular changes in the vasculature of injured tissues In vivo tumor cell targeting with "click" nanoparticles.Successful expansion but not complete restriction of tropism of adeno-associated virus by in vivo biopanning of random virus display peptide libraries Treatment of peritoneal carcinomatosis by targeted delivery of the radio-labeled tumor homing peptide bi-DTPA-[F3]2 into the nucleus of tumor cells.Potential role of vascular targeted therapy to combat against tumor.A novel peptide (GX1) homing to gastric cancer vasculature inhibits angiogenesis and cooperates with TNF alpha in anti-tumor therapy C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration.Targeting TNF-alpha for cancer therapy.Peptidic tumor targeting agents: the road from phage display peptide selections to clinical applications.Peptide-based probes for targeted molecular imaging.Novel target for peptide-based imaging and treatment of brain tumors Gene delivery mediated by recombinant silk proteins containing cationic and cell binding motifs.HMGNs, DNA repair and cancer.Targeting of drugs and nanoparticles to tumors.Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs Synthesis and investigation of a radioiodinated F3 peptide analog as a SPECT tumor imaging radioligand HMGN2, a new anti-tumor effector molecule of CD8⁺ T cells.F3-targeted cisplatin-hydrogel nanoparticles as an effective therapeutic that targets both murine and human ovarian tumor endothelial cells in vivo.Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology.A surface-charge study on cellular-uptake behavior of F3-peptide-conjugated iron oxide nanoparticles Are quantum dots ready for in vivo imaging in human subjects?Systematic surface engineering of magnetic nanoworms for in vivo tumor targeting Tissue-penetrating delivery of compounds and nanoparticles into tumors.Magnetic Iron Oxide Nanoworms for Tumor Targeting and Imaging.Spider silk-based gene carriers for tumor cell-specific delivery.Targeted imaging and therapy of brain cancer using theranostic nanoparticles 111In-BnDTPA-F3: an Auger electron-emitting radiotherapeutic agent that targets nucleolin Tumor penetrating peptides for improved drug delivery.Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels Cancer treatment using peptides: current therapies and future prospects The cargo of CRPPR-conjugated liposomes crosses the intact murine cardiac endothelium.Near-infrared quantum dots as optical probes for tumor imaging.

P2860

Q24538147-C01B4DEA-71E8-4F15-A251-A93A66076D57 Q27024850-E5248AA1-76AB-4416-BC31-6A423DDB1D6E Q28263669-3642086E-AE0F-4FF1-8450-57AF44860B8C Q29871435-4A92BE00-F004-43DE-8EC8-23A9D45AEFAD Q30426518-B02E1FB1-E33F-4EE4-8057-DBEA7B2F9383 Q30472645-11A7426A-F881-4146-8F16-29F46D96FD71 Q33246815-A596756A-87C0-4BB4-A652-942C86BED017 Q33251692-1B5D8612-414F-4762-BF50-75D723D6FC94 Q33289271-3FAD7E42-91C1-47DA-AA31-24CC3D385BE2 Q33350022-E388C72B-AC9D-4816-81FA-F7EE6B982300 Q33428576-F301D340-0CD5-437B-98A4-8B21A04045A6 Q33455875-8BE75291-3219-4E7B-BAF3-D13B279B1A0A Q33470615-849AF3BB-7E39-4FBD-B2E9-7E177A93B1F2 Q33501372-5A993EFE-3899-413B-A9AD-A21C0AC75FCA Q33508760-A275CF18-CC51-415F-99AD-8FFA23B3A1C7 Q33513307-82435F40-0B3A-4EFD-BDB9-D57A0034AD5A Q33520512-E936445D-FE70-47BD-A4BC-BCD4628D333F Q33526620-C79B2545-052D-4C7D-8B39-B2A55829961C Q33554409-18DA2E86-B787-4404-B7AF-2B3A7FE7DC67 Q33574252-9A35C291-F674-4FAB-8767-1247A7A87F93 Q33731091-FE6ABCD1-202A-4747-B769-1BF101195E6E Q33751710-EC963610-28FC-4F15-8277-FCA261A2DC9A Q33897492-9BE5B867-C3C9-4DBE-9A2E-8A47AA49F83F Q33979930-34470A85-E0B5-449F-95AD-1EDC9E34300F Q34020224-0BF3EF8E-A496-454E-9533-F79CCBF19CA1 Q34268119-073D5AF8-4017-41C3-82A0-2466E4C13AD5 Q34447986-439506F4-5E64-4B70-962F-7F5B26CE1A44 Q34627416-9A8BF4C5-A38A-426D-B4F4-8969B13A1242 Q34632573-DAE73B25-A63D-47AD-9B4A-ED73CDAD99E3 Q34684423-7796AAEE-FCFD-452F-A5BE-E142A63EC94E Q35016106-7FFE9D43-5D2D-4EF0-A3DA-0174D71F2A10 Q35047373-CED001D4-AC9B-47C5-853E-9BC721E3101B Q35169072-AD3118F2-90DB-40C9-81E3-E355DB9C41CD Q35792897-B723232D-412F-4775-9BEE-B864FF1D95DC Q35819235-DC7CC000-5F09-44CF-82FB-493812F78966 Q35978545-E451991E-5DBB-4CF7-A5ED-2B1056D21C52 Q36324866-01077AA2-101E-44C3-AF83-41D6311DB565 Q36515785-B273AADF-55FF-4856-867B-6ED4FF5F3742 Q36555535-1C4039BC-2873-4A85-869B-52F21B414ABC Q36777322-41CE4674-5F1E-4AD9-A6FA-AF76D43E4AE8

P2860

A fragment of the HMGN2 protein homes to the nuclei of tumor cells and tumor endothelial cells in vivo

http://www.wikidata.org/entity/Q24530544

description

2002 nî lūn-bûn

@nan

2002 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

name

A fragment of the HMGN2 protei ...... umor endothelial cells in vivo

@ast

A fragment of the HMGN2 protei ...... umor endothelial cells in vivo

@en

A fragment of the HMGN2 protei ...... umor endothelial cells in vivo

@en-gb

A fragment of the HMGN2 protei ...... umor endothelial cells in vivo

@nl

type

label

A fragment of the HMGN2 protei ...... umor endothelial cells in vivo

@ast

A fragment of the HMGN2 protei ...... umor endothelial cells in vivo

@en

A fragment of the HMGN2 protei ...... umor endothelial cells in vivo

@en-gb

A fragment of the HMGN2 protei ...... umor endothelial cells in vivo

@nl

prefLabel

A fragment of the HMGN2 protei ...... umor endothelial cells in vivo

@ast

A fragment of the HMGN2 protei ...... umor endothelial cells in vivo

@en

A fragment of the HMGN2 protei ...... umor endothelial cells in vivo

@en-gb

A fragment of the HMGN2 protei ...... umor endothelial cells in vivo

@nl

P1433

Q24530544-150BED15-1AD9-416C-8757-7DC58CAF094E

P1476

Q24530544-318DE4C3-CAD1-41AC-9EEB-59769E53CC12

P2093

Q24530544-3D03D122-DDA4-4AFE-A9B0-039F6B9AFF68

P2860

Q24530544-0170C0D9-C53E-4B8C-80A7-FFE8F5788CCE

Q24530544-0F384147-5D8A-4C85-B696-BCB1C7EB027E

Q24530544-1922F369-FE69-45F0-A94C-63623CA9AF17

Q24530544-1961BB55-C874-43C8-87D5-A2C57E3EB948

Q24530544-24EAC0D4-839E-4C37-8FC6-7913A647C7CE

Q24530544-25358EF7-9502-48C2-A353-B4C5BC3C885C

Q24530544-298471D7-4881-43BC-ACD8-86CAE1F06A67

Q24530544-332E0326-A3AC-430A-972A-DDB13334BF09

Q24530544-362DC1C8-D93A-401E-BDE5-28CC64673541

Q24530544-40CFFFB3-D31C-4C33-B657-3F1D5E19E7BF

P304

Q24530544-40536909-FA7A-4CFB-9161-4D9CE3C52473

P31

Q24530544-BF6487C4-2995-4D88-B3F5-0EB8BCBA3896

P3181

Q24530544-B1BED747-6709-4756-9CE4-238724DBCFC1

P356

Q24530544-DDA348C1-6D2B-4202-AA12-CB8AF7126D5E

P407

Q24530544-DAD256BE-C61A-4613-A7BE-7A473B78A687

P433

Q24530544-A0C5385A-7A64-4A43-9C2D-8EA713E4DB91

P478

Q24530544-4C9B81FD-B4DE-464D-8659-C9CDB78C95CE

P50

Q24530544-5CF2768A-E37F-4AC2-A2B6-AB83B86B6B7A

Q24530544-BFF68DE7-8819-4F7D-BFD7-C334EAF1ED23

Q24530544-C916A2A1-CECF-43DF-93D5-D97B6925082D

Q24530544-E0BC23AE-B90E-4900-9D2C-AF4890ED83B2

P577

Q24530544-AE0C127D-F0BF-4923-B6C3-276827080157

P5875

Q24530544-F0EEF8FB-A315-4566-90CE-5CB96D3901A7

P698

Q24530544-6214E5C7-8CBC-4E90-A03F-CCFD1C85BF3D

P921

Q24530544-B7C1C55F-FA57-480D-926D-9843BCFDCE1D

P932

Q24530544-77CD095C-9703-4071-8676-1EC9B41DDE90

P3181

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

A fragment of the HMGN2 protei ...... umor endothelial cells in vivo

@en

P2093

Jason A Hoffman

http://www.w3.org/2001/XMLSchema#string

P2860

The Hallmarks of Cancer

Genes expressed in human tumor endothelium

Delineation of mRNA export pathways by the use of cell-permeable peptides

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts

Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

Cell surface tumor endothelial markers are conserved in mice and humans

Isolation of putative progenitor endothelial cells for angiogenesis

NG2 proteoglycan is expressed exclusively by mural cells during vascular morphogenesis

The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system

P304

7444-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3685612

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.062189599

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

99

http://www.w3.org/2001/XMLSchema#string

P50

Michele Bernasconi

Pirjo Laakkonen

Erkki Ruoslahti

P577

2002-05-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11340810

http://www.w3.org/2001/XMLSchema#string

P698

12032302

http://www.w3.org/2001/XMLSchema#string

P921

P932

124250

http://www.w3.org/2001/XMLSchema#string